Skip to content
AnalystLens

CME GROUP INC.CME

Sector
Other
Industry
Security & Commodity Brokers, Dealers, Exchanges & Services
Exchange
Nasdaq

Stock Price $CME

Latest filings

You are here#19 of 58 in Financials by market cap

Filing record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Nov ’19Nov ’19
  3. Material agreement8-K · Nov ’21Nov ’21
  4. Leadership change8-K · Sep ’25Sep ’25

01—Key figures

Source: 10-KFY2025
Source: 10-KFY2025
Source: 10-KFY2025
Source: 10-KFY2025

Revenue Trend

Year-over-year comparison from 10-K annual reports

  19. $6.52B
YoY changeLargest recent move+18.2%in FY18Latest +6.4%

1 older move runs past ±20% (largest +45.8%); point at, tap or drag across the bars to read one.

Latest bar from 10-KFY2025Click a bar to open its SEC filing

View full history →
All CME Financial Metrics55 metrics

Income Statement10

Balance Sheet25

Cash Flow15

Per Share5

02—Overview

CME GROUP INC. Financial Overview 2021–2025

Updated Jul 10, 2026

Driven by a record average daily volume of 28.1 million contracts, CME Group expanded its net income by 15% to $4.07 billiona in FY2025. The derivatives exchange functions as a highly efficient financial toll road, successfully converting geopolitical uncertainty and interest rate volatility into persistent top-line growth and capital returns.

The company's scale and operational leverage are clear across a multi-year timeline. Total revenue steadily expanded from $4.69 billion in FY2021 to $6.52 billionb in FY2025, fueled by expanding clearing and transaction fees. Beyond core trading, market data and information services grew by 13% in FY2025, proving consistent demand for its proprietary analytics. The financial engine is protected by strict expense management; even with heavy technology investments to migrate core applications to Google Cloud by Q1 2026, CME Group maintained a 69.7% operating margin in Q1 2026.

This compounding cash flow directly supports a $3.0 billion share repurchase programc and an annual variable dividend framework. At the close of FY2025, the market valued the exchange's entrenched position by pricing the stock at $273.08, representing a 24.5x P/E ratio on $11.16 in full-year earnings per share.

Recent Developments (Q4 2025 and Q1 2026)

CME Group named Lynne C. Fitzpatrick as CEO, effective March 1, 2027, succeeding Terrence A. Duffy. Q1 2026 revenue reached $1.88 billiond, a 14% year-over-year gain. Clearing and transaction fees totaled $1.54 billion alongside a 22% increase in total contract volume. Q1 2026 net income expanded 21% to $1.15 billion, equating to $3.18 per share. The company repurchased $539 million in stock during Q1 2026 and expanded its credit facility to a $7 billion base.

The 22% volume increase supports a bull case for transaction revenue. The bear case centers on technology and compensation costs, which pushed operating expenses up 7% to $570.4 millione. The stock traded at 25.5x earnings as of April 24, 2026.

What to watch: CFO search progress; Class B shareholder voting resolutions

03—Filings

Recent SEC Filings

  1. 8-KCME GROUP INC. 8-K Report, Bylaw Amendment (Sep 25, 2026)CME Group Inc. has filed a certificate of elimination with the Delaware Secretary of State, effective September 24, 2026. This action formally removes provisions related to the Company's Series G Non-Voting Convertible Preferred Stock from its certificate of incorporation. Importantly, no shares of this Series G Preferred Stock were ever issued or outstanding at the time of this filing, meaning this is a procedural cleanup of the corporate charter rather than a change impacting existing shareholders or capital structure. Investors can consider this filing a housekeeping matter that simplifies the Company's foundational corporate documents. The elimination of the Series G Preferred Stock provisions does not alter CME Group's current operational status, financial standing, or the rights and obligations associated with its currently issued shares. The full details of the certificate of elimination are available as an exhibit to this 8-K filing for those seeking further specifics.
  2. 8-KCME GROUP INC. 8-K Report, Executive Changes (Sep 9, 2026)CME Group Inc. (CME) announced significant changes in its senior finance and legal leadership through an 8-K filing on September 9, 2026. The most notable development is the continuation of Jack Tobin's tenure with the company, as he will now assume the role of Chief Financial Officer (CFO) in March 2027, succeeding Lynne Fitzpatrick who is transitioning to CEO. This appointment marks a shift from Mr. Tobin's previously announced retirement plans. In conjunction with these changes, Matthew Render has been appointed as the Managing Director, Chief Accounting Officer, effective November 2, 2026, succeeding Mr. Tobin in this role. Mr. Render brings extensive experience from his previous roles at Citadel and BP. These appointments are designed to ensure continuity and a smooth transition in critical financial oversight functions as the company navigates its executive leadership evolution.
  3. 8-KCME GROUP INC. 8-K Report, Regulation FD Disclosure (Aug 11, 2026)CME Group Inc. (CME) filed a Form 8-K on August 11, 2026, primarily to disclose a change in its pricing structure communicated to clients through Special Executive Report No. 9799. While the specifics of the pricing adjustments are not detailed in this 8-K, the filing indicates that this information has been made available to clients and posted on the company's website. Investors should note that this filing is made under Regulation FD and is for disclosure purposes, not to trigger specific financial reporting requirements. The information provided is not deemed "filed" under the Securities Exchange Act of 1934, meaning it doesn't carry the same legal implications as other types of filings, and will not be incorporated by reference into other SEC filings unless explicitly stated.
  4. 8-KCME GROUP INC. 8-K Report, Financial Results (Jul 22, 2026)CME Group Inc. (CME) has filed an 8-K report on July 22, 2026, to disclose its financial results for the quarter ended June 30, 2026. The filing primarily incorporates by reference a press release (Exhibit 99.1) containing these results. Investors should note that the press release includes both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures. While the company provides non-GAAP figures for revenues, expenses, operating income, net income, and earnings per share, it's crucial for investors to understand that these are supplemental measures and not a replacement for GAAP reporting.
  5. 8-KCME GROUP INC. 8-K Report, Executive Changes (Jun 17, 2026)CME Group Inc. (CME) announced a significant leadership transition, with current Chairman and CEO Terrence A. Duffy transitioning to Executive Chairman and President and CFO Lynne C. Fitzpatrick succeeding him as Chief Executive Officer. This leadership change, effective on the later of March 1, 2027, or the filing of the 2026 10-K, aims to ensure leadership continuity and leverage Duffy's extensive experience in a strategic oversight role while elevating Fitzpatrick, a long-tenured executive with deep financial and operational expertise, to lead the company. The transition plan outlines specific arrangements for both executives. Mr. Duffy will continue as CEO until the transition date and then serve as Executive Chairman through December 31, 2027, with his compensation and benefits largely remaining consistent. Ms. Fitzpatrick will assume the CEO role and a board seat on the transition date, with a new compensation package including a $1.2 million base salary, a 200% target bonus, and a 700% long-term incentive opportunity. The company has also commenced a search for Ms. Fitzpatrick's successor as CFO.
View all 8-K filings →
View all filings (10-K, 10-Q, 8-K, proxy & more) →

04—See also

Related Companies

Annual revenue over each company’s last eight fiscal years, each strip on its own scale from zero.